Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) Posts Basic Consolidated EPS Of $-1.9869

0

Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX)managed to report annual basic consolidated EPS of $-1.9869, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-1.9869 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.5231.

EPS contribution from parent

Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) received of $-1.9869 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) contributed EPS of $-1.9869 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-1.9869.

What About Basic net EPS

The basic net EPS that Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) reported for the year ended 2015-12-31 stood at $-1.99. For the quarter ended 2015-12-31, the company posted basic net EPS of $-1.99.

What About Consolidated Diluted EPS?

Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-1.9869. For the quarter ended 2015-12-31 the metric was$-1.9869.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-1.9869 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-1.9869.

Net diluted EPS

Net diluted EPS posted by Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) for the year ended 2015-12-31 was $-1.99. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-1.99.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) said that it parent company boosted its diluted EPS by$-1.9869 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-1.9869.

The company reported net basic EPS of $-1.99 for the year ended 2015-12-31 and net basic EPS of $-1.99 for the quarter ended 2015-12-31.

The number of Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 9.433. That compares with 9.433 basic shares outstanding for the quarter ended 2015-12-31.

Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) had 9.433 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 9.433.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 2 times, 1 visits today)